Stahl Stephanie M, Manchanda Shalini, Parker Noah, Chernyak Yelena
Division of Pulmonary, Critical Care, Sleep and Occupational Medicine, Department of Medicine, Indiana University School of Medicine, 714 N. Senate Ave, Indianapolis, IN, 46202, USA.
Department of Neurology, Indiana University School of Medicine, 714 N. Senate Ave, Indianapolis, IN, 46202, USA.
J Clin Psychol Med Settings. 2023 Mar;30(1):43-50. doi: 10.1007/s10880-022-09885-6. Epub 2022 Jun 6.
Obstructive sleep apnea (OSA) and insomnia are common sleep disorders that often occur concurrently. The presence of one of these disorders often negatively impacts the other, including affecting treatment benefit and adherence. While insomnia has been shown to adversely affect positive airway pressure therapy adherence, minimal data are currently available on the effects of insomnia on upper airway stimulation (UAS) therapy for the treatment of OSA. We present two cases that highlight the negative impact of insomnia on UAS therapy usage and OSA management as well as the benefits of insomnia treatment on overall outcomes. Screening for and treatment of insomnia prior to UAS implantation are recommended.
阻塞性睡眠呼吸暂停(OSA)和失眠是常见的睡眠障碍,常常同时发生。其中一种障碍的存在往往会对另一种产生负面影响,包括影响治疗效果和依从性。虽然已有研究表明失眠会对持续气道正压通气治疗的依从性产生不利影响,但目前关于失眠对治疗OSA的上气道刺激(UAS)疗法的影响的数据极少。我们介绍两例病例,突出失眠对上气道刺激疗法的使用和阻塞性睡眠呼吸暂停管理的负面影响,以及失眠治疗对总体治疗效果的益处。建议在植入上气道刺激装置之前筛查并治疗失眠。